Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Novel molecular biomarkers' response to a cardiac rehabilitation programme in patients with ischaemic heart diseases
Mehani SHM
European Journal of Physiotherapy 2018;20(4):235-243
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

OBJECTIVE: Few data are available on the effect of resistance exercise training combined with endurance training (circuit training) on new molecular biomarkers which are considered as early independent risk factors for atherosclerosis progression. The purpose of the present study was to evaluate the effect of a cardiac rehabilitation programme (CRP), on homocysteine (Hcy), apolipoprotein A1, peak VO2 and muscle strength in patients with stable angina pectoris. METHOD: A total of 40 male patients with stable angina pectoris class I and class II according to the NYHA classification were recruited. Their ages ranged between 40 and 50 years. Patients were randomly divided into two groups: group (A), the training group who received CRP for three months and group (B), the control group. RESULTS: At the end of the programme, the study group (A) showed a significant reduction in homocysteine along with a significant increase in ApoA1, peak VO2 and muscle strength, while the control group showed a non-significant increase in homocysteine, peak VO2 and muscle strength along with a non-significant decrease in ApoA1. There was a negative strong correlation between Hcy and apolipoprotein A1 (r = -0.76, p = 0.0001), between Hcy and peak VO2 (r = -0.81, p = 0.0001) and strong positive correlation between peak VO2 and ApoA1 in the study group. CONCLUSION: It could be concluded that CRP reduced serum Hcy levels with an increase in apolipoprotein A1, peak VO2 and muscle strength in patients with angina pectoris.

Full text (sometimes free) may be available at these link(s):      help